Avanos Medical (AVNS) Total Non-Current Liabilities (2013 - 2026)

Avanos Medical has disclosed Total Non-Current Liabilities across 14 years of filings, most recently posting $253.9 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $253.9 million, down 3.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $253.9 million (down 3.79% YoY), and the FY2025 annual result was $282.0 million, down 12.23% from the prior year.
• Total Non-Current Liabilities came in at $253.9 million for Q1 2026 at Avanos Medical, down from $282.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $487.2 million in Q3 2023 to a low of $253.9 million in Q1 2026.
• The 5-year median for Total Non-Current Liabilities is $420.7 million (2023), against an average of $388.1 million.
• Across the five-year window, Total Non-Current Liabilities jumped 48.48% in 2022 and tumbled 39.24% in 2025, its largest moves.
• Avanos Medical's Total Non-Current Liabilities stood at $475.2 million in 2022, then slipped by 6.12% to $446.1 million in 2023, then declined by 27.98% to $321.3 million in 2024, then decreased by 12.23% to $282.0 million in 2025, then slipped by 9.96% to $253.9 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $253.9 million (Q1 2026), $282.0 million (Q4 2025), and $269.0 million (Q3 2025), per Business Quant data.